Literature DB >> 25481286

Differential tolerance of 'pseudo-pathogenic' tryptophan residues in calcium-binding EGF domains of short fibulin proteins.

Annie Nguyen1, John D Hulleman2.   

Abstract

An Arg345Trp (R345W) mutation in the last canonical calcium-binding epidermal growth factor (cbEGF) domain of fibulin-3 (F3) causes the rare macular dystrophy, Malattia Leventinese (ML). In cell culture studies, this mutation leads to inefficient F3 secretion and higher intracellular steady state levels, likely due to F3 disulfide bonding and/or protein folding problems. However, how the R345W mutation actually causes ML is still largely unknown. Herein we tested whether the introduction of analogous, 'pseudo-pathogenic' tryptophan mutations immediately after the bn cysteine (bn+1) in other cbEGF domains also caused protein folding/secretion challenges. We found that introduction of tryptophan mutations into each of the four other F3 canonical cbEGF domains caused a significant reduction in protein secretion ranging from 2.7 to 56% of wild-type (WT) F3 levels. Surprisingly, an R185W mutation in the first canonical cbEGF domain of F3 yielded the highest amount of secretion among the F3 tryptophan mutants, and its secretion defect could be rescued to near WT levels (95%) after growth temperature reduction. Interestingly, when similarly positioned tryptophan mutations were introduced into any of the canonical cbEGF domains of the highly homologous protein, fibulin-5 (F5), there was no effect on secretion. In an attempt to make F3 tolerant of tryptophan residues (like F5), we genetically engineered F3 to have a higher sequence homology with F5 by deleting three insert regions present in F3, but not F5. However, deletion of one or more of these regions did not have a beneficial effect on R345W F3 secretion. Overall, these results demonstrate that the introduction of tryptophan residues at the bn+1 position does not universally disrupt cbEGF domain folding and secretion, but that their effect is context dependent, and in this case, uniquely disrupt the folding of canonical cbEGF domains of F3, but not F5.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium binding epidermal growth factor domains; Fibulin-3; Fibulin-5; Malattia Leventinese; Protein misfolding; Tryptophan mutations

Mesh:

Substances:

Year:  2014        PMID: 25481286      PMCID: PMC4551491          DOI: 10.1016/j.exer.2014.12.002

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  22 in total

1.  COBALT: constraint-based alignment tool for multiple protein sequences.

Authors:  Jason S Papadopoulos; Richa Agarwala
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

2.  Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction.

Authors:  Michel Michaelides; Sharon A Jenkins; Milam A Brantley; Richard M Andrews; Naushin Waseem; Vy Luong; Kevin Gregory-Evans; Shomi S Bhattacharya; Fred W Fitzke; Andrew R Webster
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

3.  A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion.

Authors:  John D Hulleman; Steven J Brown; Hugh Rosen; Jeffery W Kelly
Journal:  J Biomol Screen       Date:  2012-12-10

4.  Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression.

Authors:  C Nathaniel Roybal; Lihua Y Marmorstein; David L Vander Jagt; Steve F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

Review 5.  Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review.

Authors:  Lihua Marmorstein
Journal:  Ophthalmic Genet       Date:  2004-09       Impact factor: 1.803

6.  Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa.

Authors:  Andrew J Lotery; Dominique Baas; Caroline Ridley; Richard P O Jones; Caroline C W Klaver; Edwin Stone; Tomoyuki Nakamura; Andrew Luff; Helen Griffiths; Tao Wang; Arthur A B Bergen; Dorothy Trump
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

7.  Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice.

Authors:  Precious J McLaughlin; Benjamin Bakall; Jiwon Choi; Zhonglin Liu; Takako Sasaki; Elaine C Davis; Alan D Marmorstein; Lihua Y Marmorstein
Journal:  Hum Mol Genet       Date:  2007-09-13       Impact factor: 6.150

8.  Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration.

Authors:  Lihua Y Marmorstein; Precious J McLaughlin; Neal S Peachey; Takako Sasaki; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2007-07-30       Impact factor: 6.150

9.  The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.

Authors:  Li Fu; Donita Garland; Zhenglin Yang; Dhananjay Shukla; Anand Rajendran; Erik Pearson; Edwin M Stone; Kang Zhang; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2007-07-30       Impact factor: 6.150

10.  The disulfide folding pathway of human epidermal growth factor.

Authors:  J Y Chang; P Schindler; U Ramseier; P H Lai
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

View more
  6 in total

1.  Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.

Authors:  Donna S Mackay; Thomas M Bennett; Alan Shiels
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

2.  Conditional, Genetically Encoded, Small Molecule-Regulated Inhibition of NFκB Signaling in RPE Cells.

Authors:  Khiem T Vu; Fang Zhang; John D Hulleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

3.  A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye - Implications for Ocular Gene Therapy.

Authors:  Shyamtanu Datta; Marian Renwick; Viet Q Chau; Fang Zhang; Emily R Nettesheim; Daniel M Lipinski; John D Hulleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

4.  Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.

Authors:  DaNae R Woodard; Emi Nakahara; John D Hulleman
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

5.  Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism.

Authors:  Annie Nguyen; John D Hulleman
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

6.  A Novel Luciferase Assay For Sensitively Monitoring Myocilin Variants in Cell Culture.

Authors:  Serena Zadoo; Annie Nguyen; Gulab Zode; John D Hulleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.